TLDR Blocking the KATP channel may help treat migraines.
The document explores ATP-sensitive potassium (KATP) channels as a novel target for migraine treatment, highlighting their role in migraine pathogenesis. Current treatments are effective for only 50-60% of patients, necessitating new approaches. KATP channel activation is a potent headache trigger, with agonists like levcromakalim inducing migraines in 100% of patients without aura. Blocking these channels could offer new therapeutic options, but existing blockers like glibenclamide are non-specific and ineffective. The study emphasizes the need for selective KATP blockers, particularly targeting the Kir6.1/SUR2B subtype, and calls for further research to assess their efficacy and safety, especially regarding cardiac implications. The research was supported by the BRIDGE Programme and Candys Foundation, with no major conflicts of interest.
3 citations
,
May 2022 in “Journal of The American Academy of Dermatology” The conclusion is that 24 weeks of low-dose oral minoxidil is safe for men with hair loss, with no significant changes in heart rate or blood pressure.
119 citations
,
June 2005 in “Journal of Molecular and Cellular Cardiology” Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.
5 citations
,
September 2022 in “Molecular pharmacology” KATP channels are important for energy balance and are targeted by drugs for diabetes, hypoglycemia, hypertension, and hair loss.
119 citations
,
June 2005 in “Journal of Molecular and Cellular Cardiology” Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.
3 citations
,
March 2012 in “Arab Journal of Urology” Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.
119 citations
,
October 1992 in “Fundamental & Clinical Pharmacology” Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.
1 citations
,
June 2023 in “Frontiers in Pharmacology” Vasodilators may worsen abdominal aortic aneurysm.